| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
CD274 molecule | 0.324 | 0.923 | 1.9E-02 |
|
phenotype | 0.100 | None | 1.000 | 80 | 0 | 2011 | 2020 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
phenotype | 0.100 | None | 0.958 | 71 | 0 | 1995 | 2020 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
phenotype | 0.100 | None | 1.000 | 63 | 0 | 1996 | 2019 | ||||||||
|
tripartite motif containing 13 | 0.462 | 0.846 | 0.64 |
|
phenotype | 0.100 | None | 1.000 | 54 | 0 | 2002 | 2020 | ||||||||
|
CXADR Ig-like cell adhesion molecule | 0.454 | 0.885 | 0.37 |
|
phenotype | 0.100 | None | 1.000 | 54 | 0 | 2002 | 2020 | ||||||||
|
arrestin 3 | 0.460 | 0.846 | 0.10 |
|
phenotype | 0.100 | None | 1.000 | 54 | 0 | 2002 | 2020 | ||||||||
|
protein kinase cAMP-dependent type I regulatory subunit alpha | 0.401 | 0.846 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 54 | 0 | 2002 | 2020 | ||||||||
|
CXADR pseudogene 1 | 0.463 | 0.846 |
|
phenotype | 0.100 | None | 1.000 | 54 | 0 | 2002 | 2020 | |||||||||
|
SPG7 matrix AAA peptidase subunit, paraplegin | 0.436 | 0.885 | 2.0E-36 |
|
phenotype | 0.100 | None | 1.000 | 54 | 0 | 2002 | 2020 | ||||||||
|
calcium sensing receptor | 0.410 | 0.846 | 4.7E-02 |
|
phenotype | 0.100 | None | 1.000 | 54 | 0 | 2002 | 2020 | ||||||||
|
nuclear receptor subfamily 1 group I member 3 | 0.448 | 0.846 | 3.5E-08 |
|
phenotype | 0.100 | None | 1.000 | 54 | 0 | 2002 | 2020 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
phenotype | 0.100 | None | 0.959 | 49 | 3 | 1991 | 2019 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
phenotype | 0.100 | None | 1.000 | 48 | 0 | 1989 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
phenotype | 0.400 | None | 1.000 | 47 | 0 | 2005 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta | 0.319 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 37 | 0 | 2005 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta | 0.322 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 36 | 0 | 2005 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma | 0.320 | 0.885 | 1.4E-06 |
|
phenotype | 0.100 | None | 1.000 | 36 | 0 | 2005 | 2020 | ||||||||
|
hypoxia inducible factor 1 subunit alpha | 0.327 | 0.923 | 0.98 |
|
phenotype | 0.100 | None | 1.000 | 34 | 0 | 2000 | 2019 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 19 | 2 | 2004 | 2019 | ||||||||
|
signal transducer and activator of transcription 3 | 0.320 | 0.923 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 19 | 0 | 2009 | 2018 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
phenotype | 0.100 | None | 0.944 | 18 | 0 | 1995 | 2019 | ||||||||
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
phenotype | 0.100 | None | 0.938 | 16 | 1 | 2013 | 2019 | ||||||||
|
SET domain containing 2, histone lysine methyltransferase | 0.424 | 0.846 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 16 | 0 | 2004 | 2018 | ||||||||
|
kinase insert domain receptor | 0.378 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 15 | 0 | 2011 | 2020 | ||||||||
|
MET proto-oncogene, receptor tyrosine kinase | 0.380 | 0.846 | 0.97 |
|
phenotype | 0.100 | None | 1.000 | 15 | 0 | 1991 | 2020 |